Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.
about
Effects of Cardiovascular Risk Factors on Endothelial Progenitor CellCardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature reviewAn Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesIncreased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients.An anti-CD34 antibody-functionalized clinical-grade POSS-PCU nanocomposite polymer for cardiovascular stent coating applications: a preliminary assessment of endothelial progenitor cell capture and hemocompatibility.Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions.Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri LankaNon-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diseaseCardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease.Endothelial progenitor cells in acute myocardial infarction and sleep-disordered breathing.Association between echocardiographic epicardial fat thickness and circulating endothelial progenitor cell level in patients with stable angina pectoris.
P2860
Q27025888-ED967EAB-820B-474F-8D5B-C02F4700157AQ28081066-9F481231-EFED-4A3F-9CC2-83D26B550A04Q30382499-C35D7AAF-9112-4A21-A0E4-A213B41B14BEQ33807117-BAE6A4D8-E6D9-423C-8007-5A42E319F092Q34728267-42FA5250-2076-48C2-AD6B-FF29A5435CD4Q34849981-35E7C5CF-58D5-4FEB-AE37-4EE504E2955CQ35015083-142BD27E-2E3A-4C37-A52F-912467086A55Q35124843-3D36057A-DF3B-4353-82B3-C5A76C3101BCQ35921598-30FEFA8F-9423-489C-AA90-D794FEFE9C1DQ37002532-9E1702B2-E6C2-4467-9D20-8E92827DAC18Q38974667-7520FDCE-A74C-4D7C-A808-7165D4BD5867Q42679082-3C60F6B9-B2AA-4A62-A5F1-D72B36F489B4Q44299935-9FA36E27-E272-4263-900F-A836F3F25AC2Q47899630-D0F3F140-B64D-4758-8088-0E73BF2655B2
P2860
Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Decreased circulating endothel ...... alcoholic fatty liver disease.
@ast
Decreased circulating endothel ...... alcoholic fatty liver disease.
@en
Decreased circulating endothel ...... alcoholic fatty liver disease.
@nl
type
label
Decreased circulating endothel ...... alcoholic fatty liver disease.
@ast
Decreased circulating endothel ...... alcoholic fatty liver disease.
@en
Decreased circulating endothel ...... alcoholic fatty liver disease.
@nl
prefLabel
Decreased circulating endothel ...... alcoholic fatty liver disease.
@ast
Decreased circulating endothel ...... alcoholic fatty liver disease.
@en
Decreased circulating endothel ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P1433
P1476
Decreased circulating endothel ...... alcoholic fatty liver disease.
@en
P2093
Chia-Hung Chiang
Chin-Chou Huang
Fa-Po Chung
Hsin-Bang Leu
Jaw-Wen Chen
Po-Hsun Huang
Shing-Jong Lin
Tao-Cheng Wu
Zu-Yin Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0031799
P407
P577
2012-02-16T00:00:00Z